Asset Allocation

As of November 30, 2025.
Type % Net
Cash 6.49%
Stock 77.93%
Bond 14.25%
Convertible 0.00%
Preferred 0.00%
Other 1.33%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 89.60%
Mid 9.31%
Small 1.09%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 91.89%    % Emerging Markets: 0.43%    % Unidentified Markets: 7.68%

Americas 89.99%
89.55%
Canada 1.12%
United States 88.43%
0.44%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.19%
United Kingdom 1.26%
0.89%
France 0.01%
Germany 0.00%
Ireland 0.32%
Netherlands 0.56%
Switzerland 0.00%
0.00%
0.04%
Israel 0.04%
Greater Asia 0.14%
Japan 0.03%
0.10%
Australia 0.10%
0.00%
Singapore 0.00%
South Korea 0.00%
0.00%
Unidentified Region 7.68%

Bond Credit Quality Exposure

AAA 1.27%
AA 0.30%
A 0.39%
BBB 0.69%
BB 0.17%
B 0.05%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.23%
Not Available 96.91%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
13.91%
Materials
0.98%
Consumer Discretionary
12.61%
Financials
0.31%
Real Estate
0.00%
Sensitive
73.51%
Communication Services
15.47%
Energy
0.48%
Industrials
2.89%
Information Technology
54.67%
Defensive
10.67%
Consumer Staples
4.43%
Health Care
4.82%
Utilities
1.41%
Not Classified
1.92%
Non Classified Equity
0.15%
Not Classified - Non Equity
1.77%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 95.99%
Corporate 0.95%
Securitized 2.94%
Municipal 0.00%
Other 0.11%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
96.19%
Less than 1 Year
96.19%
Intermediate
1.16%
1 to 3 Years
0.52%
3 to 5 Years
0.39%
5 to 10 Years
0.25%
Long Term
2.61%
10 to 20 Years
0.95%
20 to 30 Years
1.00%
Over 30 Years
0.66%
Other
0.05%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial